These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17827007)

  • 1. Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.
    Van HT; Le QM; Lee KY; Lee ES; Kwon Y; Kim TS; Le TN; Lee SH; Cho WJ
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5763-7. PubMed ID: 17827007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
    Cho WJ; Le QM; My Van HT; Youl Lee K; Kang BY; Lee ES; Lee SK; Kwon Y
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3531-4. PubMed ID: 17498951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modification of 3-arylisoquinolines to isoindolo[2,1-b]isoquinolinones for the development of novel topoisomerase 1 inhibitors with molecular docking study.
    Van HT; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2551-4. PubMed ID: 19328687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.
    Khadka DB; Le QM; Yang SH; Van HT; Le TN; Cho SH; Kwon Y; Lee KT; Lee ES; Cho WJ
    Bioorg Med Chem; 2011 Mar; 19(6):1924-9. PubMed ID: 21353568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.
    Lee SH; Van HT; Yang SH; Lee KT; Kwon Y; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2444-7. PubMed ID: 19345580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.
    Cho WJ; Min SY; Le TN; Kim TS
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4451-4. PubMed ID: 14643344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
    Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
    Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors.
    Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem; 2004 Oct; 12(19):5147-60. PubMed ID: 15351398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
    Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.
    Ioanoviciu A; Antony S; Pommier Y; Staker BL; Stewart L; Cushman M
    J Med Chem; 2005 Jul; 48(15):4803-14. PubMed ID: 16033260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.
    Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ
    Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.
    Nagarajan M; Morrell A; Fort BC; Meckley MR; Antony S; Kohlhagen G; Pommier Y; Cushman M
    J Med Chem; 2004 Nov; 47(23):5651-61. PubMed ID: 15509164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel autoxidative cleavage reaction of 9-fluoredenes discovered during synthesis of a potential DNA-threading indenoisoquinoline.
    Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    J Org Chem; 2004 Oct; 69(22):7495-501. PubMed ID: 15497974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxicity and topoisomerase inhibition properties of multifarious aminoalkylated indeno[1,2-c]isoquinolin-5,11-diones.
    Ahn G; Schifano-Faux N; Goossens JF; Baldeyrou B; Couture A; Grandclaudon P; Lansiaux A; Ryckebusch A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2259-63. PubMed ID: 21439821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.
    Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M
    J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
    Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
    J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.
    Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.
    Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M
    J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Arylisoquinolines as novel topoisomerase I inhibitors.
    Khadka DB; Cho WJ
    Bioorg Med Chem; 2011 Jan; 19(2):724-34. PubMed ID: 21095131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.